Akari Therapeutics Plc

Ownership Transactions Reported by 13 Insiders

Symbol
AKTX on Nasdaq
Location
22 Boston Wharf Road, Fl 7, Boston, MA

There are no Buy or Sell transactions made by insiders since 4/23/2024

Akari Therapeutics Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Hoyoung Huh Director, 10%+ Owner $16.8M Mar 20, 2025
Raymond Prudo-Chlebosz Director $10.7M Mar 20, 2025
Samir Rashmikant Patel Director $8.06M Mar 20, 2025
Sandip I. Patel Director $1.8M Mar 20, 2025
Abizer Gaslightwala Director $604K Mar 20, 2025
Robert B. Bazemore Director $150K Mar 20, 2025
James R. Neal Director $70K Mar 20, 2025
Torsten Hombeck Cfo $468 Mar 20, 2025
Mohamed Wa'el Ahmed Hashad Director Jun 28, 2024
Wendy F. Dicicco Interim CFO May 1, 2024
Rachelle Suzanne Jacques Chief Executive Officer, Director Apr 26, 2024
Donald A. Williams Director Jun 28, 2024
Michael Grissinger Director Jun 28, 2024

Recent Insider Transactions by Companies or Individuals for Akari Therapeutics Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.